A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib

Journal of Thoracic Oncology

Volumn 7, Issue 10, 2012, Pages

  Gautschi, Oliver ^a   Pauli, Chantal ^a   Strobel, Klaus ^a   Hirschmann, Astrid ^a   Printzen, Gert ^a   Aebi, Stefan ^a   Diebold, Joachim ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; B RAF KINASE V600E; BLEOMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; K RAS PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TORASEMIDE; UNCLASSIFIED DRUG; VEMURAFENIB;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DYSPNEA; EXON; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HOARSENESS; HUMAN; HYPERTENSION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURGICAL DRAINAGE; TREATMENT RESPONSE;

EID: 84866595717     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182629903     Document Type: Article

References (5)

1. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012;366:707-714.
2. Chapman PB, Hauschild A, Robert C, et al.; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507-2516.
3. Kris MG, Johnson BE, Kwiatkowski DJ, et al. Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC). J Clin Oncol 2011;29 (Suppl): abstr CRA7506.
4. Marchetti A, Felicioni L, Malatesta S, et al. Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. J Clin Oncol 2011;29:3574-3579.
5. Pratilas CA, Hanrahan AJ, Halilovic E, et al. Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res 2008;68:9375-9383.